EP3494972
COMBINATIONS OF DOLUTEGRAVIR AND LAMIVUDINE FOR THE TREATMENT OF HIV INFECTION
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.1.2011EP published:
13.12.2023EP application number:
19151897.6
EP translation filed:
26.2.2024Grant published:
15.3.2024EPO information:
European Patent Register
Max expiry date:
23.1.2031Expiry date:
23.1.2027Next due date:
31.1.2027
Title in English:
COMBINATIONS OF DOLUTEGRAVIR AND LAMIVUDINE FOR THE TREATMENT OF HIV INFECTIONLanguage of the patent:
English
Timeline
Today
24.1.2011EP application
13.12.2023EP Publication
26.2.2024Translation submitted
15.3.2024Registration published
23.1.2027Expires
Owner
Name:
VIIV Healthcare CompanyAddress:
251 Little Falls Drive, Wilmington, DE 19808, US
Inventor
Name:
UNDERWOOD, Mark RichardAddress:
NC North Carolina 27709, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
29858910 PDate:
27.1.2010Country:
US
Supplementary protection
SPC number:
SPC471
Classification
Categories:
A61K 31/513, A61K 31/5365, A61K 45/06, A61K 9/00, A61P 31/00, A61P 31/12, A61P 31/18, A61P 37/04, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 23.1.2024
Expires: 23.1.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.1.2025
Expires: 23.1.2026
Payer: Árnason Faktor ehf.
Number: 16
Paid: 12.1.2026
Expires: 23.1.2027
Payer: Árnason Faktor ehf.